Condition

Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials and research

Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 years

As of November 12, 2026, Find a Trial lists 9 Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (6), Canada (1), South Korea (1)). By phase: Early Phase 1 (2), Phase 1/2 (2), Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials

StudyPhaseWhereStatusRegistered
Samuraciclib given before surgery or chemotherapy for certain pancreatic cancers Phase 1 Seattle, Washington Recruiting Jun 12, 2026
PULSAR personalized ultrafractionated adaptive proton radiotherapy combined with systemic therapy for pancreatic cancer Phase 2 Seoul, Select Province/State Recruiting Dec 8, 2025
XER-001 (nasoduodenal amifostine) with SBRT for locally advanced pancreatic cancer Phase 1/2 Duarte, California and 4 other locations Recruiting Sep 5, 2025
GnP plus serplulimab with stereotactic body radiation therapy for first-line locally advanced pancreatic cancer. Phase 2 Chengdu, Sichuan Recruiting Aug 3, 2025
OMO-103 for advanced or metastatic pancreatic ductal adenocarcinoma Early Phase 1 Portland, Oregon Recruiting Jul 29, 2025
Using advanced MRI to assess treatment response in pancreatic cancer — San Francisco, California Recruiting Sep 19, 2024
Tumor DNA and protein testing to understand pancreatic cancer treatment response — Vancouver, British Columbia Recruiting Aug 28, 2024
Combining zimberelimab and quemliclustat with chemotherapy for advanced pancreatic cancer Phase 1/2 Los Angeles, California Recruiting Jan 18, 2023
Targeted therapy for pancreatic cancer using new drugs Early Phase 1 Portland, Oregon Recruiting Jul 2, 2019

All recruiting trials (9)

Related topics

Borderline Resectable Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaPancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaSerplulimabZimberelimab

Quick answers

How many Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (6 trials), Canada (1 trial), South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2, Phase 1/2: 2, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.